Metropolis Healthcare Bonus Shares: Check Details From Record Date To Allotment Date; Target Price Inside

The record date for its corporate action in the form of bonus shares has been declared by Metropolis Healthcare Limited, one of the top and most well-known Indian diagnostics companies with its headquarters in Mumbai. Following the announcement, shares of Metropolis Healthcare Ltd. (METROPOLIS) last traded on the NSE on March 13, 2026, at Rs 1,810.00, down 0.76% from the previous close. The stock traded between an intraday high of Rs 1,835.00 and a low of Rs 1,801.00 during the most recent session, which began at Rs 1,825.00. Metropolis Healthcare has produced a return of almost 11.89% over the last year, and its price has been well within the 52-week range of Rs 1,315.00 to Rs 2,263.00.

Metropolis Healthcare Bonus Shares Record Date

"This is in reference to our previous intimations dated February 04, 2026, and March 09, 2026, regarding the recommendation of the Board of Directors of the Company and subsequent approval of the shareholders (via Postal Ballot) of the Company, for the issuance of Bonus Equity Shares in the ratio of 3:1, i.e., Three (3) new fully paid-up Equity Shares of face value of INR 2/- (Indian Rupees Two only) each for every One (1) existing fully paid-up Equity Share of face value of INR 2/- (Indian Rupees Two only) each," said Metropolis Healthcare in a stock exchange filing.

The Board of Directors of the company, via circular resolution passed on March 10, 2026, has fixed the Record Date as Friday, March 20, 2026 for the purpose of determining entitlement of equity shareholders for the purpose of issuing bonus equity shares in the ratio of 3:1.

"Further, in accordance with SEBI Circular No. CIR/CFD/PoD/2024/122 dated September 16, 2024, the deemed date of allotment of Bonus Equity Shares shall be Monday, March 23, 2026," Metropolis Healthcare has further informed stock exchanges.

Metropolis Healthcare Target Price

"Investors who prefer accumulating at lower levels can always opt to pick Metropolis Healthcare at these levels, as the company has a very strong medical diagnostic business model. Metropolis Healthcare, running in a downward falling channel, has formed a good double bottom on the level of Rs. 1745-1750 while in a continuous downtrend, with RSI below 40 and running below major moving averages. Although in a downtrend, it may give a good bounce up to Rs. 1960. Buying at Rs. 1800 - 1810 with stop loss of Rs.1725 and target of Rs. 1950 seems to be a good trade now," commented Market Wizard's Adib Noorani.

About Metropolis Healthcare

Metropolis Healthcare Limited is the second-largest diagnostic chain in India, having been founded in 1981. Metropolis has been a leader in providing top-notch diagnostic services to individuals, healthcare professionals, and corporates throughout India and Africa for more over 40 years. With a strong network of 219 laboratories, more than 4,800 patient service settings and more than 10,000 touchpoints, the firm has a wide presence throughout 28 states, 7 Union Territories, and more than 750 towns in India.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred to as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.